Experience the power of CHIMERA, the modular biofabrication platform from Ourobionics that sets a new standard in regenerative medicine.

A new technology developed at MIT enables scientists to label proteins across millions of individual cells in fully intact 3D tissues with unprecedented speed, uniformity, and versatility.

Researchers at the University of Toronto's Faculty of Applied Science & Engineering have used machine learning to design nano ...

Using toolpath-optimized deposition-based methods, an team of researchers has proposed an innovative approach to 3D-print ...

When 3D printing was first introduced in 1985, it marked a major turning point for the manufacturing industry. In addition to ...

Irish researchers have developed a way of bioprinting tissues that change shape as a result of cell-generated forces, in the ...

Researchers have developed a way of bioprinting tissues that change shape as a result of cell-generated forces, in the same way that it happens in biological tissues during organ development. The ...

Researchers at University of Galway have developed a way of bioprinting tissues that change shape as a result of ...

Researchers develop 3D blood-brain barrier model to study Alzheimers and neuroinflammation New platform created to improve ...

Sales Analysis Pharmaceutical companies are increasingly integrating 3D bioprinting technology into their drug development ...

Barclays PLC grew its position in 3D Systems Co. (NYSE:DDD – Free Report) by 260.1% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 207,379 shares of the 3D printing company’s ...

Personalized Medicine : By combining iPSCs with genome-editing technologies like CRISPR, scientists can introduce precise genetic modifications, such as knock-outs, knock-ins, or single base changes, ...